Cellectis
Why Robinhood?
You can watch Cellectis and buy or sell other stocks, ETFs, and their options commission-free!About CLLS
Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J.
CLLS Key Statistics
Stock Snapshot
The current Cellectis(CLLS) stock price is $4.68, with a market capitalization of 353.38M. The stock trades at a price-to-earnings (P/E) ratio of -14.04.
During the trading session on 2025-12-13, Cellectis(CLLS) shares reached a daily high of $5.05 and a low of $4.62. At a current price of $4.68, the stock is +1.3% higher than the low and still -7.3% under the high.
Trading activity shows a volume of 167.78K, compared to an average daily volume of 118.46K.
The stock's 52-week range extends from a low of $1.10 to a high of $5.48.
The stock's 52-week range extends from a low of $1.10 to a high of $5.48.
CLLS News
TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRank...